Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Alpelisib is the first PI3K inhibitor specifically for PIK3CA-mutated breast cancer and can be used in combination with fulvestrant to significantly prolong progression-free surviv···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：522
Alpelisib was approved by the FDA in 2019 for the treatment of breast cancer patients with HR/HER2- and PIK3CA mutations. By inhibiting the PI3K signaling pathway, Alpelisib effect···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：523
Alpelisib is the first PI3Kα inhibitor to be used in combination with fulvestrant for the treatment of HR/HER2- breast cancer. By targeting the PIK3CA mutation, Alpelisib significa···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：582
Balversais a new target anti-cancer star, specializing in FGFR-positive cancers, providing patients with precision treatment options, although effective, it is necessary to pay att···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：475
Balversa, an innovative anti-cancer targeted drug, accurately snipes FGFR-positive tumors and opens up new hope for patients with advanced cancer.What diseases is Balversasuitable ···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：510
Balversa is an innovative targeted therapy that effectively inhibits the growth of cancer cells for FGFR-positive tumors, bringing new treatment options to patients, but they need ···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：524
Balversa, a new targeted anti-cancer drug, provides new treatment hope for patients with advanced cancer by precisely inhibiting the FGFR signaling pathway.Is Balversaexpensive? Ho···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：466
Balversa is a novel targeted anti-cancer drug that inhibits the FGFR signaling pathway for the treatment of advanced cancer, providing patients with precision treatment options and···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：416
Balversais an oral, targeted anti-cancer drug that specifically inhibits the FGFR signaling pathway and is used to treat specific types of advanced cancers, such as urothelial carc···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：518
Balversais an oral anticancer drug targeting FGFR mutations for the treatment of specific types of cancer, such as urothelial carcinoma, and provides patients with new therapeutic ···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：471
Balversais a new oral anti-cancer drug targeting FGFR, which is specially designed for cancer patients with FGFR gene mutations, precisely inhibiting tumor growth, and providing ne···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：448
Balversais an oral tyrosine kinase inhibitor for the treatment of non-small cell lung cancer and urothelial carcinoma, among others, and provides a new treatment option for patient···【more】
Article source：Captain MedicineRelease date：2024-08-26Recommended：418
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8532025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10502024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：3112026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4052026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：5982026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：5712026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4562026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6072026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
